Investors in Business Development

We are Mocha Ventures, and our pioneering endeavor, MOCHAX, represents a groundbreaking approach in the realm of venture capital investment through tokenization. As a security token offering (STO), MOCHAX aims to democratize access to venture capital opportunities by leveraging blockchain technology to tokenize traditional venture capital assets. By transforming startup equity and tokens into tradable digital assets, we enable investors to participate in venture capital investments with increased liquidity, transparency, and accessibility. We invest in early-stage blockchain projects that are transforming from Web2 to Web3, solving real business problems, have existing users and paying customers, and can survive and thrive in the bear market and explode in the bull market. We enable accredited and institutional investors to diversify their portfolios and thrive in the new era of digital assets, thus shaping the future of the global economic landscape.

Slingshot Ventures is a dynamic venture capital firm specializing in early-stage investments across technology sectors, including software, internet platforms, digital media, and emerging technologies. Founded to support innovation and entrepreneurial drive, Slingshot Ventures focuses on backing startups with disruptive potential and scalable business models. Typically investing during Seed and Series A stages, the firm provides critical capital to help startups validate their ideas, develop products, and accelerate growth. Beyond financial support, Slingshot Ventures offers strategic guidance and access to a network of industry experts and mentors, aiming to empower portfolio companies to achieve market traction and long-term success. With a commitment to fostering innovation and driving positive impact, Slingshot Ventures plays a pivotal role in nurturing the growth of early-stage technology companies and contributing to advancements in the global tech landscape.

Tyson & Blake is committed to investing in inspiring founders who bring innovative approaches and technologies that deliver positive impact and long-term value. With a focus on supporting visionary entrepreneurs, Tyson & Blake identifies and nurtures ventures that have the potential to create meaningful change in their respective industries. By providing strategic capital and operational support, Tyson & Blake aims to empower these founders to realize their visions and achieve sustainable growth and success.

Plural, we specialize in empowering early-stage startups that are innovating across various industries. Our firm is dedicated to supporting visionary entrepreneurs who drive forward disruptive technologies and business models. We offer not only financial backing but also strategic guidance and operational expertise to help our portfolio companies achieve sustainable growth and success.

Oxford Science Enterprises is a venture firm partnered with universities, specializing in early-stage investments across life sciences, AI & software, and deep technology sectors. The firm leverages its close ties with academia to identify and support innovative startups with transformative potential. Oxford Science Enterprises provides strategic capital and operational expertise to help these ventures navigate their early growth phases and achieve market leadership. By focusing on cutting-edge technologies and scientific advancements, the firm aims to drive significant innovation and impact in global markets.

VP Capital is a global investment vehicle specializing in the technology sector. As an investment firm, VP Capital focuses on identifying and supporting innovative technology companies worldwide. They provide strategic capital and operational support to help these companies accelerate their growth and achieve market leadership. VP Capital leverages its global network and industry expertise to identify promising investment opportunities and empower entrepreneurs to drive innovation and success in the technology sector. Their commitment lies in fostering the development of transformative technologies and contributing to the advancement of the global tech ecosystem.

Northzone, we are a technology investment partnership with over two decades of experience. We have earned the trust of some of the best entrepreneurs who choose us as their long-term growth partner. With offices across the Nordics, London, and New York, we work tirelessly to connect our portfolio companies with customers, business partners, and top talent on a global scale. As former entrepreneurs ourselves, we have experienced the challenges and opportunities from both sides of the table. Our approach is rooted in building strong relationships with our founders, placing their success and vision at the core of our business strategy.

Kerdos Ventures, we specialize in investing in early-stage and growth-stage companies with significant growth potential. Our focus sectors include technology, healthcare, consumer goods, and other innovative industries. We aim to provide more than just capital; we offer strategic support and industry expertise to help our portfolio companies thrive and achieve their full potential.

Founded in 2008 by and for founders, Newfund Capital is an early-stage VC firm actively investing in France and the USA. We foster a strong entrepreneurial culture and support the ambitions of our portfolio companies through various initiatives. With $300 million in assets under management (AUM), primarily subscribed by entrepreneurs and family offices, Newfund focuses on a people-driven investment strategy. We prioritize entrepreneurs who are deeply committed to realizing their vision, valuing their individuality and strengths. Our initial investments range from $250k to $2M, with smaller commitments starting at $100k in the Nouvelle Aquitaine region through our NAEH fund. Beyond financial support, we offer access to our operating team and a robust cross-border ecosystem to help founders achieve product-market fit and accelerate growth. At Newfund, we emphasize founders with significant skin in the game, reflecting our own commitment as a major limited partner (LP) in each fund. Our interests are fully aligned with those of our portfolio companies, ensuring a partnership without conflicts of interest.

Integra Holdings is a unique venture fund that combines academic excellence, funding and R&D guidance together with a strong and proven business network — the most important elements necessary to bring academic innovation to the market. Focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in their respective fields, Integra takes a hands-on approach by providing our portfolio companies the strategic planning and business development necessary to bring their technology to the market. Founded by Yissum, the Hebrew University's technology transfer company, Integra capitalizes on the innovative applied research constantly flowing from the renowned Hebrew University of Jerusalem, Israel.

Verve Ventures is a network and technology-driven venture capital firm headquartered in Switzerland. Founded in 2010, Verve Ventures has grown to more than 45 team members and has become one of the most active venture investors in Europe with over 140 technology and science-driven startups in its portfolio. A dozen investment professionals identify the most promising digital, tangible, and health & bio startups. Verve Ventures provides its pan-European network of selected private and institutional investors access to those top-tier investment opportunities.

Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus almost exclusively on oncology therapeutics, and on helping to drive value creation for our portfolio companies. We invest in the most promising drug discovery companies with the potential to create multiple medicines. Our portfolio is focused throughout the US and Europe with investments from company inceptions to crossover rounds. Finding and fueling tomorrow's advances in precision medicine.